Vertex Pharmaceuticals Incorporated (FRA:VX1)

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had revenue of $3.08B USD in the quarter ending September 30, 2025, with 10.99% growth. This brings the company's revenue in the last twelve months to $11.69B, up 10.04% year-over-year. In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B with 11.66% growth.

• Revenue (ttm): $11.69B
• Revenue Growth: +10.04%
• P/S Ratio: 10.13
• Revenue / Employee: $1.92M
• Employees: 6,100
• Market Cap: 101.18B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.02B	1.15B	11.66%
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%
Dec 31, 2019	4.16B	1.12B	36.59%
Dec 31, 2018	3.05B	558.95M	22.46%
Dec 31, 2017	2.49B	786.48M	46.20%
Dec 31, 2016	1.70B	669.84M	64.89%
Dec 31, 2015	1.03B	451.92M	77.86%
Dec 31, 2014	580.42M	-631.56M	-52.11%
Dec 31, 2013	1.21B	-315.07M	-20.63%
Dec 31, 2012	1.53B	116.42M	8.25%
Dec 31, 2011	1.41B	1.27B	883.91%
Dec 31, 2010	143.37M	41.48M	40.71%
Dec 31, 2009	101.89M	-73.62M	-41.94%
Dec 31, 2008	175.50M	-23.51M	-11.81%
Dec 31, 2007	199.01M	-17.34M	-8.02%
Dec 31, 2006	216.36M	55.47M	34.47%
Dec 31, 2005	160.89M	-	-